Clinical trials
Recurrence trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 5 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 5 |
| Genmab | 2 |
| Antisoma Research | 1 |
| Aptose Biosciences Inc. | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| BeOne Medicines | 1 |
| BeiGene | 1 |
| Celgene | 1 |
| Centocor, Inc. | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 22 |
| Leukemia, Myeloid, Acute | 5 |
| Multiple Myeloma | 4 |
| Multiple Sclerosis | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Neoplasms | 3 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.